ALXO
ALX Oncology·NASDAQ
--
--(--)
--
--(--)
ALXO fundamentals
ALX Oncology (ALXO) released its earnings on Feb 27, 2026: revenue was 0 (YoY --), met estimates; EPS was -0.42 (YoY +23.64%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.42
+23.64%
Report date
Feb 27, 2026
ALXO Earnings Call Summary for Q4,2025
- $150M Financing Boosts Cash to $188.7M: Sufficient for clinical trials through mid-2028.
- EVO Phase II Breast Trial Expanded to 120 Patients: Focused on CD47-high subset with 65% response rate in gastric cancer.
- ALX-2004 Safety Data Expected H2 2026: ADC shows no ILD/skin toxicity in preclinical studies.
- CD47 Biomarker Validation: 92% CR in NHL, 56% response in breast cancer trials; post-ENHERTU patients have higher CD47 expression.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
ALX Oncology (ALXO) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
ALX Oncology (ALXO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
ALX Oncology (ALXO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
ALX Oncology (ALXO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does ALX Oncology (ALXO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track ALX Oncology (ALXO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for ALX Oncology next quarter?What guidance did ALX Oncology's management provide for the next earnings period?What were the key takeaways from ALX Oncology’s earnings call?What is the revenue and EPS growth rate for ALX Oncology year over year?What is ALX Oncology's latest dividend and current dividend yield?Did ALX Oncology beat or miss consensus estimates last quarter?What is ALX Oncology's gross profit margin?What factors drove the changes in ALX Oncology's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
